Cargando…
Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report
Fetal tachycardia (FT) is a rare disorder and is associated with significant mortality of fetus. Digoxin is one of the antiarrhythmic agents used to treat FT via transplacental therapy. In this report, we describe a therapeutic drug monitoring (TDM) case of digoxin during the treatment of FT. A 40-y...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253450/ https://www.ncbi.nlm.nih.gov/pubmed/35800665 http://dx.doi.org/10.12793/tcp.2022.30.e11 |